# Quanta Computer

Type: Company (2382.TW)

Source: Space & Defense Intelligence Brief — https://getspacebrief.com/entity/quanta-computer
Canonical HTML page: https://getspacebrief.com/entity/quanta-computer

## Timeline

- **2026-12-22**: Lorundrostat PDUFA Date — Target date for FDA decision on Mineralys' lead product candidate.
- **2026-06-01**: Nektar Phase 3 Launch — Nektar plans first patient randomization for its Atopic Dermatitis program.
- **2026-03-12**: Mineralys NDA Acceptance — FDA accepts Mineralys' NDA for lorundrostat for uncontrolled hypertension.
- **2025-12-31**: EHang Record Deliveries — EHang closes Q4 with 100 eVTOL units delivered and first GAAP profit.
- **2025-12-01**: HeartBeam FDA Clearance — HeartBeam secures 510(k) clearance for 12-lead ECG synthesis software.

## Recent coverage (1 stories)

### EHang Hits Profitability Milestone as eVTOL and AR Sectors Scale for 2026
2026-03-13 00:09:12 · Sentiment: Bullish · Impact: 7/10 · Sources: 15

EHang (EH) achieved its first quarterly GAAP profit on record eVTOL deliveries, signaling a commercial inflection point for Advanced Air Mobility. Simultaneously, Vuzix (VUZI) reported a 76% revenue surge in smart glasses and waveguide technology, underscoring robust demand for dual-use augmented reality systems.
Full story: https://getspacebrief.com/story/ehang-vuzix-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getspacebrief.com/guides/methodology for the full editorial methodology.